This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Buggins AG, Milojkovic D, Arno MJ, Lea NC, Mufti GJ, Thomas NS et al. Microenvironment produced by acute myeloid leukemia cells prevents T cell activation and proliferation by inhibition of NF-kappaB, c-Myc, and pRb pathways. J Immunol 2001; 167: 6021–6030.
Milojkovic D, Devereux S, Westwood NB, Mufti GJ, Thomas NS, Buggins AG . Antiapoptotic microenvironment of acute myeloid leukemia. J Immunol 2004; 173: 6745–6752.
Lea NC, Orr SJ, Stoeber K, Williams GH, Lam EW, Ibrahim MA et al. Commitment point during G0 → G1 that controls entry into the cell cycle. Mol Cell Biol 2003; 23: 2351–2361.
Parker JE, Mufti GJ, Rasool F, Mijovic A, Devereux S, Pagliuca A . The role of apoptosis, proliferation, and the Bcl-2-related proteins in the myelodysplastic syndromes and acute myeloid leukemia secondary to MDS. Blood 2000; 96: 3932–3938.
Conzen SD, Gottlob K, Kandel ES, Khanduri P, Wagner AJ, O'Leary M et al. Induction of cell cycle progression and acceleration of apoptosis are two separable functions of c-Myc: transrepression correlates with acceleration of apoptosis. Mol Cell Biol 2000; 20: 6008–6018.
Ravandi F, Kantarjian HM, Talpaz M, O'Brien S, Faderl S, Giles FJ et al. Expression of apoptosis proteins in chronic myelogenous leukemia: associations and significance. Cancer 2001; 91: 1964–1972.
Ayanlar-Batuman O, Shevitz J, Traub UC, Murphy S, Sajewski D . Lymphocyte interleukin 2 production and responsiveness are altered in patients with primary myelodysplastic syndrome. Blood 1987; 70: 494–500.
Chang WC, Fujimiya Y, Casteel N, Pattengale P . Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. III. Defective interleukin-2 production by T-helper and natural killer cells. Int J Cancer 1989; 43: 591–597.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Milojkovic, D., Buggins, A., Devereux, S. et al. Tumor supernatant from myeloid malignancies inhibits T-cell apoptosis and cell cycle entry independently. Leukemia 19, 1699–1702 (2005). https://doi.org/10.1038/sj.leu.2403864
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2403864